ABBV logo

AbbVie (ABBV) Long Term Liabilities

Annual Total Long Term Liabilities

$86.47 B
-$5.51 B-5.99%

31 December 2023

ABBV Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$94.29 B
+$1.09 B+1.17%

30 September 2024

ABBV Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABBV Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.0%+5.6%
3 y3 years-20.5%-11.7%
5 y5 years+71.0%+87.9%

ABBV Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-20.5%at low-11.7%+9.0%
5 y5 years-20.5%+71.0%-14.4%+87.9%
alltimeall time-20.5%+5076.6%-14.4%+6808.8%

AbbVie Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$94.29 B(+1.2%)
June 2024
-
$93.20 B(-6.1%)
Mar 2024
-
$99.31 B(+14.8%)
Dec 2023
$86.47 B(-6.0%)
$86.47 B(-3.2%)
Sept 2023
-
$89.32 B(-1.0%)
June 2023
-
$90.23 B(-3.7%)
Mar 2023
-
$93.65 B(+1.8%)
Dec 2022
$91.98 B(-4.1%)
$91.98 B(-0.7%)
Sept 2022
-
$92.59 B(-1.5%)
June 2022
-
$94.03 B(-0.4%)
Mar 2022
-
$94.38 B(-1.6%)
Dec 2021
$95.90 B(-11.9%)
$95.90 B(-10.2%)
Sept 2021
-
$106.75 B(+0.1%)
June 2021
-
$106.69 B(+1.8%)
Mar 2021
-
$104.82 B(-3.7%)
Dec 2020
$108.81 B(+33.2%)
$108.81 B(-1.2%)
Sept 2020
-
$110.15 B(-0.0%)
June 2020
-
$110.15 B(+34.1%)
Mar 2020
-
$82.14 B(+0.5%)
Dec 2019
$81.70 B(+61.6%)
$81.70 B(+62.8%)
Sept 2019
-
$50.17 B(+2.9%)
June 2019
-
$48.77 B(-3.8%)
Mar 2019
-
$50.69 B(+0.3%)
Dec 2018
$50.56 B
$50.56 B(-5.8%)
Sept 2018
-
$53.70 B(+12.4%)
June 2018
-
$47.79 B(-1.9%)
DateAnnualQuarterly
Mar 2018
-
$48.73 B(-0.6%)
Dec 2017
$49.05 B(-5.1%)
$49.05 B(-0.1%)
Sept 2017
-
$49.12 B(+0.8%)
June 2017
-
$48.73 B(-6.0%)
Mar 2017
-
$51.82 B(+0.3%)
Dec 2016
$51.68 B(+35.3%)
$51.68 B(+1.2%)
Sept 2016
-
$51.05 B(-2.4%)
June 2016
-
$52.30 B(+36.1%)
Mar 2016
-
$38.41 B(+0.5%)
Dec 2015
$38.21 B(+165.8%)
$38.21 B(-7.2%)
Sept 2015
-
$41.16 B(+11.0%)
June 2015
-
$37.09 B(+159.9%)
Mar 2015
-
$14.27 B(-0.7%)
Dec 2014
$14.38 B(-19.3%)
$14.38 B(-16.3%)
Sept 2014
-
$17.17 B(-1.9%)
June 2014
-
$17.51 B(-1.3%)
Mar 2014
-
$17.74 B(-0.5%)
Dec 2013
$17.83 B(+5.7%)
$17.83 B(+0.2%)
Sept 2013
-
$17.80 B(+1.4%)
June 2013
-
$17.55 B(+0.6%)
Mar 2013
-
$17.45 B(+3.4%)
Dec 2012
$16.87 B(+897.0%)
$16.87 B(+896.2%)
Sept 2012
-
$1.69 B(+24.1%)
June 2012
-
$1.36 B(-2.2%)
Mar 2012
-
$1.40 B(-17.5%)
Dec 2011
$1.69 B(+1.3%)
$1.69 B
Dec 2010
$1.67 B
-

FAQ

  • What is AbbVie annual total long term liabilities?
  • What is the all time high annual total long term liabilities for AbbVie?
  • What is AbbVie annual total long term liabilities year-on-year change?
  • What is AbbVie quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for AbbVie?
  • What is AbbVie quarterly long term liabilities year-on-year change?

What is AbbVie annual total long term liabilities?

The current annual total long term liabilities of ABBV is $86.47 B

What is the all time high annual total long term liabilities for AbbVie?

AbbVie all-time high annual total long term liabilities is $108.81 B

What is AbbVie annual total long term liabilities year-on-year change?

Over the past year, ABBV annual total long term liabilities has changed by -$5.51 B (-5.99%)

What is AbbVie quarterly total long term liabilities?

The current quarterly long term liabilities of ABBV is $94.29 B

What is the all time high quarterly long term liabilities for AbbVie?

AbbVie all-time high quarterly total long term liabilities is $110.15 B

What is AbbVie quarterly long term liabilities year-on-year change?

Over the past year, ABBV quarterly total long term liabilities has changed by +$4.97 B (+5.56%)